Immunotherapy for Recurrent Pregnancy Loss: “Standard of Care of Buyer Beware”

1. Zinamen MJ , Clergy ED , Brown CC , O'Connor J . Selam SG . Estimate of human fertility and pregnancy loss. Fertil Steril 1996;65:505-509.

2. Robert CJ , Lowe CR . Where have all the conceptions gone? Lancet 1975;i:498-499.

3. Alberman E . The epidemiology of repeated abortion. In: Beard RW , Sharp F , eds. Early pregnancy loss: mechanisms of treatment. London: Springer-Verlag, 1988:9-17.

4. Sagan C . The demon haunted world: Science as a candle in the dark. New York: Ballantine Books, 1996.

5. Russell B . Mysticism and logic. 1929.

6. Boue J , Boue A , Laser P . Retrospective and prospective epidemologic studies of 1,500 karyotyped spontaneous abortions. Teratology 1975;11:11-26.

7. Warbarton D , Fraser FC . On the probability that a woman who has had a spontaneous abortion will abort subsequent pregnancies. Br J Obstet Gynaecol 1961;68:784-787.

8. Hill JA , Polgar K , Anderson DJ . T helper 1 type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 1995;273:1933-1936.

9. Hill JA , Haimovici F , Anderson DJ , Products of activated lymphocytes and macrophages inhibit mouse embryo development in vitro. J Immunol 1987;139:2250-2254.

10. Berkowitz RS , Hill JA , Kurtz RS , Anderson DJ . Effects of products of activated lekocytes (lymphokines and monokines) on the growth of malignant trophoblast cells in vitro. Am J Obstet Gynecol 1988;158:199-203.

11. Hill JA , Polgar K , Harlow BL , Anderson DJ . Evidence of embryo and trophoblast toxic cellular immune response(s) in women with recurrent spontaneous abortion. Am J Obstet Gynecol 1992;166:1044-1052.

12. Polgar K Yacono PW , Golan DE , Hill JA . Immune interferon gamma inhibits translational mobility of a plasma membrane protein in preimplantation stage mouse embryos: A T-helper 1 mechanism for immunologic reproductive failure. Am J Obstet Gynecol 1996;174:282-287.

13. Rocklin RE , Kitzmiller JL , Carpenter CB , Garovoy MR , David JR . Maternal-fetal relation: Absence of an immunologic blocking factor from serum of women with chronic abortions. N Engl J Med 1976;295:1209-1215.

14. Sargent IL , Williams T , Redman CWG . Maternal immune responses to the fetus in early pregnancy and recurrent miscarriage. Lancet 1994;11:1099-1104.

15. Rocklin RE , Kitzmiller JL , Garvey MR . Maternal-fetal relation: Further characterization for an immunologic blocking factor that develops during pregnancy. Clin Immunol Immunopathol 1982;22:505-515.

16. Amos DB , Kostyn DD , HLA . A central immunological agency of man. Adv Hum Genet 1980;137-141.

17. Reagan L , Baude PR , Hill DP . A prospective study of the incidence, time of appearance and the significance of antipaternal lymphocytotoxic antibodies in human pregnancy. Hum Reprod 1981;6:294-298.

18. Rodger C . Lack of a requirement for a maternal humoral immune response to establish and maintain successful allogenic pregnancy. Transplantation 1985;40:372-375.

19. Taylor C , Faulk MP . Preventing recent abortion with leukocyte transfusions. Lancet 1981;2:68-70.

20. Beer AE , Semprini AE , Zho XY , Quebberman JF . Pregnancy outcome in human couples with recurrent spontaneous abortions: HLA antigen profiles; HLA antigen sharing; female MLR blocking factors; and paternal leukocyte immunization. Exp Clin Immunogenet 1985;2:137-153.

21. Mowbray JF , Gibbings C , Lidlell H , et al. Controlled trials of treatment of recurrent spontaneous abortion by immunostimulation with paternal cells. Lancet 1985;ii:941-943.

22. Smith JB , Cowchuck FS . Immunological studies in recurrent spontaneous abortion: Effects of immunization of women with paternal mononuclear cells in lymphotoxic and mixed lymphocyte reaction blocking antibodies and correlation with sharing of HLA antigens and pregnancy outcome. J Reprod Immunol 1988;14:99-104.

23. Carp HJ , Toder V , Gazit E , et al. Immunization by paternal leukocytes for prevention of primary habitual abortion: Results of a matched control trial. Gynecol Obstet Invest 1990;29:16-21.

24. Cauchi MN , Lim D , Kloss YM , Pepperell RJ . The treatment of recurrent abortion by immunization with paternal cells: Controlled trials. Am J Reprod Immunol 1991;25:16-17.

25. Ho CN , Gill TJ , Hsieh HJ , Jiang JJ , Lee IY , Hsieh CY . Immunotherapy for recurrent spontaneous abortion in a Chinese population. Am J Reprod Immunol 1991;25:10-15.

26. Gatenby PA , Cameron K , Simes RJ , et al. Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: Results of a controlled trial. Am J Reprod Immunol 1993;29:88-94.

27. Christiansen OB , Mathiesen O , Husth M , Lauritsen JG , Grunnet N . Placebo controlled trials of active immunization with third party leukocytes in recurrent miscarriage. Acta Obstet Gynecol Scand 1993;72:1-8.

28. Hill JA . The rationale for leukocyte immunization in women with recurrent spontaneous abortion: Fact or fiction? In: Chaouat G, Mowbray J. Colloque INSERM cellular and molecular biology of the maternal-fetal relationship, Paris: John Libbey Eurotext, 1991;263-269.

29. Jang GT , Scott JR , Burmeister LF . A comparison of meta-analytic results using literature us. individual patient data. JAMA 1995;274:830-836.

30. Cowchuck FS . What's a mother to do? Analyzing trials evaluating new treatment for unexplained recurrent miscarriages and other complaints. Am J Reprod Immunol 1991;20:150-159.

31. Clark DA , Daya S . Trials and tribulations in the treatment of recurrent spontaneous abortion. Am J Reprod Immunol 1991;25:18-24.

32. Fraser EJ , Grimes DA , Schulz KF . Immunization as therapy for recurrent spontaneous abortion. A review and meta-analysis. Obstet Gynecol 1993;82:854-859.

33. The Recurrent Miscarriage Immunotherapy Trialists Group . Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol 1994;32:55-72.

34. Scott JR . Recurrent miscarriage: Overview and recommendation. Clin Obstet Gynecol 1994;37:768-773.

35. Hill JA . Immunologic factors in spontaneous abortion. In: Bronson RA , Alexander NJ , Anderson DJ , Branch DW , Kutteh WH , eds. Reproductive immunology. Cambridge: Blackwell Science, 1996:433-442.

36. Kutteh WH , Stovall DW , Scott JR . The immunologic diagnosis and treatment of recurrent pregnancy loss. Infertil Reprodu Med Clin North Am 1997;8:267-287.

37. Katz I , Fisch B , Amlt S . Ovadic J , Tadi Y . Cutaneous graft-versus-host-like reaction after paternal lymphocyte immunization for prevention of recurrent abortion. Fertil Steril 1992;57:927-929.

38. Hill JA , Anderson DJ . Blood transfusions for recurrent abortion: Is the treatment more than the disease? Fertil Steril 1986;46:152-153.

39. Dwyer JM . Manipulating the immune system with immunoglobulin. N Engl J Med 1982;320:107-116.

40. Mueller-Eckhart G , Hene O , Nepport J , et al. Preventing recurrent spontaneous abortion by intravenous immunoglobulins. Vox Sang 1989;56:151-154.

41. Coulam CB , Peters AJ , McIntyre JA , et al. The use of intravenous immunoglobulins for the treatment of recurrent spontaneous abortion. Am J Reprod Immunol 1990;22:78-78.

42. Mueller-Eckhart G . Huni O , Poltin B . IVIG to prevent recurrent spontaneous abortion. Lancet 1991;i:424-425.

43. Christiansen OB , Mathiensen O , Husth M , et al. Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with IV immunoglobulin. Hum Reprod 1995;101:1072-1077.

44. The German RSA/IVIG Group . Intravenous immunoglobulin in the prevention of recurrent miscarriage. Br J Obstet Gynaecol 1994;101:1072-1077.

45. Coulam CB , Krysa L , Stern JJ , et al. Intravenous immunoglobulin for treatment of recurrent pregnancy loss. Am J Reprod Immunol 1995;34:333-337.

46. Thornton CA , Ballow M . Safety of intravenous immunoglobulin. Arch Neurol 1993;50:135-136.

47. Csapo AL , Pulkkinen MO , Wiest WG . Effects of luteoectomy and progesterone replacement therapy in early pregnancy patients. Am J Obstet Gynecol 1993;115:759-759.

48. Siiter PK , Febres F , Clemens LE , et al. Pregesterone and maintenance of pregnancy. Is progesterone nature's immunosuppressant? Ann NY Acad Sci 1997;286:384-397.

49. Jones GDS . Some newer aspects of the management of infertility. JAMA 1949;41:1123-1123.

50. Karamardian LM , Grimes DA . Luteal phase deficiency: Effect of treatment on pregnancy rates. Am J Obstet Gynecol 1992;167:1391-1398.

51. Daya S . Efficiency of progesterone support for pregnancy in women with recurrent miscarriage: A meta-analysis of controlled trials. Br J Obstet Gypnaecol 1989;96:275-280.

52. Nova JJ , Nova AH , Blu J , et al. Estrogenous progesterone and estrogen implicated in birth defects. JAMA 1978;240:837-843.

53. Miles RA , Paulson RJ , Lobo RA , Press MF , Dahmoush L , Sauer RV . Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: A comparative study. Fertil Steril 1994;62:485-490.

54. Branch DW , Scott JR , Kochenour NU , et al. Obsteric complications associated with the lupus anticoagulant. N Engl J Med 1985;313:1322-1322.

55. Unander AM , Norberg R , Hahn L , et al. Anticardiolipin antibodies and complement in ninety-nine women with holited abortion. Am J Obstet Gynecol 1985;156:114-114.

56. Harris EN . Syndrome of the black swan. Br J Rheumatol 1986;26:324-326.

57. Endenon P , Rouwith AM , Verdy E , et al. Autoimmunity, fetal losses, lupus anticoagulant: Beginning of systemic lupus erythematosus or new autoimmune entity with gynaeco-obstetrical expression. Hum Reprod 1986;1:295-295.

58. Lockshin MD . Antiphospholipid antibody syndrome. Rheum Dis Clin North Am 1994;20:45-59.

59. Lockshin MD . Answers to the autophospholipid syndrome? N Engl J Med 1995;332:1025-1027.

60. Peaceman AM , Silver RK , McGregor SN , et al. Interlaboratory variation in antiphospholipid antibody testing. Am J Obstet Gynecol 1992;166:1780-1780.

61. Ober C , Karrison T , Harlow L , et al. Autoantibodies and pregnancy history in a healthy population. Am J Obstet Gynecol 1993;169:143-147.

62. Cowchuck FS , Fort UG . Can tests for IgA, IgG, and IgM antibodies to cardiolipin or phosphatidyl serine substitute for lupus anticoagulant alloys in screening for antiphospholipid antibodies? Autoimmunity 1994;17:119-122.

63. Kutteh WH , Wester R . Kutteh CC . Multiples of the median: Antibodies in women with recurrent pregnancy loss. Obstet Gynecol 1994;84:811-815.

64. Silver RM , Porter TF , Greenhill AG , et al. Anticardiolipin antibodies: Clinical consequences of “low titers”. Obstet Gynecol 1996;87:494-500.

65. Yetman DL , Kutteh WH . Antiphospholipid antibody levels and recurrent pregnancy loss. Prevalence of anticardiolipin antibodies. Fertil Steril 1996;66:540-546.

66. Branch DW , Silver R , Pierangeli S , Van Leeumen I , Harris EN . Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls and antiphospholipid syndrome. Obstet Gynecol 1997;89:549-555.

67. Brandt JT , Triplett DA , Alving B , et al. Criteria for the diagnosis of lupus anticoagulants: An update. Thromb Haemost 1995;74:1185-1190.

68. Carrerar LO , Vernyler J , Spitz B , et al. Lupus anticoagulant and inhibition of intrauterine growth retardation and intrauterine deaths. Br J Obstet Gynaecol 1981;88:890-890.

69. Lockshin MD , Prazin ML , Gioei S , et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985;313:512-512.

70. Cariou R , Pobelem G , Soris C , et al. Inhibition of protein C activation by established cells in the presence of lupus anticoagulant. N Engl J Med 1986;314:1193-1193.

71. Freyssinet JM , Wiesel MC , Gauchy J , et al. An IgM lupus anticoagulant that neutralizes the enbancing effect of phospholipid on purified endothelial thrombomodulin activity: A mechanism for thrombosis. Thromb Haemost 1986;55:509-509.

72. Freyssinet JM , Gauchy J , Cazemare JP . The effect of phospholipids on the activation of protein C by the human thrombin thrombomodulin complex. Biochem J 1986;238:151-151.

73. Hurley JG , Gladman DD , Rose TH , et al. Lupus pregnancy: A prospective study of placental changes. Arthritis Rheum 1988;31:358-358.

74. Dudley DJ , Mitchell MD , Branch DW . Pathophysiology of antiphospholipid antibodies: Absence of prostaglandin-mediated effects on cultural endothelium. Am J Obstet Gypnecol 1990;162:953-953.

75. Lyden TW , Ng AU , Rote NJ . Modulation of phosphatidylserine epitope expression on Bewo cells during forskolin treatment. Am J Reprod Immunol 1992;27:24-24.

76. Gleicher N , Harlow L , Zilberstein M . Regulatory effect of antiphospholipid antibodies on signal transduction: A possible model for autoantibody-induced reproductive failure. Am J Obstet Gypnecol 1992;167:637-642.

77. Branch DW . Thoughts on the mechanism of pregnancy loss associated with the antiphospholipid syndrome. Lupus 1994;3:275-280.

78. Oshiro BT , Silver RM , Scott JR , Yu H , Branch DW . Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996;87:489-493.

79. Reed JH , Wu XX , Andrea HAM , et al. Pregnancy loss in the antiphospholipid syndrome—a possible thrombogenic mechanism. N Engl J Med 1997;337:154-160.

80. DeWolf F , Carreras LO , Moerman P , Vermylen J , Van Assche A , Renaer M . Decidual vascolapathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982;142:829-834.

81. Out HJ , Kooijman CD , Bruinse HW , Derksen RH . Histopathological findings in placentae from patients with intrauterine fetal death and anti-phospholipid antibodies. Eur J Obstet Gynecol Reprod Biol 1991;41:179-186.

82. Farquarson R , Blown A , Compton A . The lupus anticogulant: A plan for pregnancy treatment? Lancet 1985;ii:842-843.

83. Ordi J , Barquinero J , Vilardelli M , et al. Fetal loss treatment in patients with antiphospholipid antibodies. Ann Rheum Dis 1989;48:798-802.

84. Guterby PA , Cameron K , Sherman RP . Pregnancy loss with phospholipid antibodies: Improved outcome with aspirin continuing treatment. Aust N Z J Obset Gypnaecol 1989;29:294-298.

85. Roseover MH , Tabsh K , Wasserstrum N , et al. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obset Gypnecol 1990;75:630-634.

86. Branch DW , Silver RM , Blackwell JL , et al. Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience. Obstet Gpynecol 1992;80:614-620.

87. Kwak JYH , Gilman-Sachs A , Beaman DK , et al. Reproductive outcome in women with recurrent spontaneous abortions of alloimmune and autoimmune causes: Preconception versus postconception treatment. Am J Obstet Gynecol 1992;166:1787-1798.

88. Mary A , Pauzner R , Carp H , et al. Treatment of patients with antiphospholipid antibodies during pregnancy. Am J Reprod Immunol 1992;28:216-218.

89. Kutteh WH . Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996;174:1584-1589.

90. Kuteh WH , Ermel LD , A clinical trial for the treatment of antiphospholipid antibody associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol 1996;35:402-407.

91. Khamashta M , Cuadrado MJ , Mujic F , Taub NA , Hunt BJ , Hughes GRV . The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993-997.

92. Cohen RRH , Regan MDL . Randonized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997;314:253-257.

93. Lubba WF , Butler WS , Palmer SJ , Liggins GC . Fetal survival after prednisone suppression of maternal lupus anticoagulant. Lancet 1983;i:1361-1363.

94. Haseyawa I , Takakuwa R , Goto S , et al. Effectiveness of prednisolone/aspirin therapy for recurrent aborters with antiphospholipid antibody. Hum Reprod 1992;7:203-207.

95. Silver RK , MacGregor SN , Sholl JS , Hobart JM , Neerhof MG , Ragin A . A comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody positive obstetric patients. Am J Obstet Gynecol 1993;169:1411-1417.

96. Larkin CA , Bombardier C , Hannah ME , et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 1997;357:148-153.

97. Lockshin MD , Druzin ML , Qamar T . Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obset Gynecol 1989;160:439-443.

98. Cowchuck FS , Reece EA , Balandan D , Branch DW , Plouffe L . Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low dose heparin treatment. Am J Obstet Gynecol 1992;166:1318-1323.

99. Ginsberg JS , Hirsch J . Use of antithrombotic agents during pregnancy. Chest 1995;108(suppl):305S-311S.

100. Shefras J , Farquharson RG . Bone density studies in pregnant women receiving heparin. Eur J Obstet Gynecol Reprod Biol 1996;65:171-174.

101. Hunt BJ , Boughty HA , Majumdar G , et al. Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies. Thromb Haemost 1997;77:39-43.

102. Yetman DL , Kutteh WH . Antiphospholipid antibody panels and recurrent pregnancy loss: Prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril 1996;66:540-546.

103. Branch DW , Silver R , Perangeli S , Leeuman IV , Harris EN . Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome. Obstet Gynecol 1997;89:549-555.

104. Sher G , Feinman M , Zouves C , et al. High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum Reprod 1994;9:2265-2269.

105. Birdsall MA , Lockwood GM , Ledger WL , Johnson PM , Chamley LM . Antiphospholipid antibodies in women having in vitro fertilization. Hum Reprod 1996;11:1185-1189.

106. Denis AL , Guido M , Adler RD , Bergh PA , Brenner C , Scott RT . Antiphospholipid antibodies and pregnancy rates and outcome in in vitro fertilization patients. Fertil Steril 1997;67:1084-1090.

107. Adosini L , Sinigaglia F . Pathogenesis and immunotherapy of autoimmune disease. Immunol Today April 1997.

108. Gajewski TF , Schell SR , Fitch FW . Evidence implicating utilization of different T cell receptor-associated signaling of pathways by Th1 and Th2 clones. J Immunol 1990;144:4110-4120.

109. Williams ME , Lichtman AH , Abbas AK . Anti CD3 antibody induces unresponsiveness to IL-2 in Th1 clones but not in Th2 clones. J Immunol 1990;44:1208-1214.

110. Weiner HC . Oral tolerance: Immune mechanisms and treatment of autoimmune disease. Immunol Today 1997;18:335-343.

111. Bermas B , Hill JA . Proliferative responses to recall antigens are associated with pregnancy outcome in women with a history of recurrent spontaneous abortion. J Clin Invest November 1997 (in press).

112. Fatham CG , Myers BD . Cyclosporin therapy for autoimmune disease. N Engl J Med 1992;236:169-165.

113. Thorbeche GJ , Shab R , Leu CH , Juruvilla AP , Hardison AM , Palladino MA . Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice. Proc Natl Acad Sci USA 1992;89:7375-7379.

114. Miller A , Lidded O , Robbers AS , Ran MB , Weiner HL . Suppressor T cells generated by and tolerization to myelin basic protein suppresses both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen specific triggerin. Proc Natl Acad Sci USA 1992;89:421-425.

115. Lockshin MD , Answers to the antiphospholipid antibody syndrome. N Engl J Med 1997;322:1025-1027.